CME/CNE Information

Activity Title Recent Advances in Treating Multiple Sclerosis: Efficacy, Risks and Place in Therapy
Topic Multiple Sclerosis
Accreditation Type AMA PRA Category 1 Credit™/ANCC Contact Hours
Release Date October 2013
Expiration Date October 31, 2014 – No longer available for credit
Estimated Time to Complete Activity 15 minutes

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:


FACULTY

Michael D. Kaufman, MD
Clinical Assistant Professor of Medicine
Director, Multiple Sclerosis Center
Carolinas Medical Center
Charlotte, North Carolina


METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CNE information.
  3. Complete the CME/CNE activity
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CNE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Your CME/CNE certificate will be available for download


TECHNICAL REQUIREMENTS

This site is best viewed using Internet Explorer 8.0 or higher, Google Chrome 29.0 or higher, Firefox 4.0 or higher. For interactive content, a broadband connection is required. For all CME/CNE activities featuring audio you must have a sound card and speakers.

Our interactive activities may require the Adobe Flash Player (available from the Adobe Web site) and Adobe Shockwave Player (available from the Adobe Web site). Both browser plug-ins are free.

Our activities may require JavaScript to be enabled on your computer.


SPONSOR

This activity is sponsored through an educational collaboration by the CMSC, NPA, and The France Foundation.


TARGET AUDIENCE

This activity is intended for neurologists, nurse practitioners, physician assistants, nurses, other health care providers involved in the management of MS.


STATEMENT OF NEED

This education is designed to assist in identifying and addressing barriers common to the optimal diagnosis, treatment, and management of patients with multiple sclerosis.


ACCREDITATION/DESIGNATION STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and The France Foundation.

The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CMSC designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APRNs.

Laurie Scudder DNP, NP, has served as Nurse Planner for this activity.

This program has been reviewed and is approved for a maximum of 0.25 hours of AAPA Category 1 CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity.

This program was planned in accordance with AAPA's CME Standards for Live Programs and for Commercial Support of Live Programs.


RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ANCC and ACCME Standards for Commercial Support of CME, the Consortium of Multiple Sclerosis Centers, Nurse Practitioner Alternatives, and The France Foundation will implement mechanisms, prior to the planning and implementation of this CME/CNE activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME/CNE activity.


DISCLOSURES

It is the policy of CMSC, NPA, and The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. CMSC, NPA, and The France Foundation have identified and resolved any and all conflicts of interest prior to the release of this activity.


Activity Staff Disclosures

The planners, reviewers, editors, staff, continuing professional education committee, or other members at the Consortium of Multiple Sclerosis Centers who control content have disclosed no relevant financial relationships.

The planners, reviewers, and staff at the Nurse Practitioner Alternatives who control content have disclosed no relevant financial relationships.

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.


Faculty Disclosure

The following faculty has indicated he has relationships with industry to disclose relative to the content of this CME/CNE activity:


UNAPPROVED USE DISCLOSURE

CMSC, NPA, and The France Foundation require CME/CNE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by educational grants from Genzyme, a Sanofi company, Novartis, and Teva.


DISCLAIMER

CMSC, NPA, and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, NPA, The France Foundation, Genzyme, a Sanofi company, Novartis, and Teva assume no liability for the information herein.


COPYRIGHT INFORMATION

Copyright © 2013 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:


PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.


CONTACT INFORMATION

If you have questions about this CME/CNE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.